These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13031947)

  • 1. Bacteriological and pharmacological studies with viomycin.
    HEIN H
    Arzneimittelforschung; 1952 Nov; 2(11):521-3. PubMed ID: 13031947
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of resistance by Mycobacterium tuberculosis to streptomycin, viomycin, and paraaminosalicylic acid.
    JOSIUKAS A; ROY TE; BOYD G
    AMA Am J Dis Child; 1952 Dec; 84(6):747-8. PubMed ID: 12996007
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriologic research on the effect of viomycin on Mycobacterium tuberculosis].
    BARTMANN K; BLISSE A; ZANDER I
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 115(3):211-22. PubMed ID: 13328762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of sensitivity threshold of Koch's bacillus to viomycin].
    GIUNIO N
    Tuberkuloza; 1955; 7(4):229-38. PubMed ID: 13312091
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new active antibiotic against Mycobacteria: viomycin].
    NITTI V
    Arch Tisiol Mal Appar Respir; 1951 Aug; 6(8):Varia, 299-304. PubMed ID: 14878565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Viomycin resistance].
    HERTEL HW; SCHOLTZE H
    Tuberkulosearzt; 1956 Jul; 10(7):405-10. PubMed ID: 13361009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Research on the bacteriostatic effect of viomycin and of the association of viomycin and streptomycin on Koch's bacilli].
    MASI A; MOGGI P
    Riv Clin Pediatr; 1951 Jul; 49(7):517-25. PubMed ID: 14883750
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE; Plikaytis BB; Shinnick TM
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viomycin, a new tuberculostatic antibiotic].
    LEVADITI C; VAISMAN A; HENRY-EVENO J; CHAIGNEAU-ERHARD H
    Rev Immunol Ther Antimicrob; 1951; 15(5-6):298-320. PubMed ID: 14942194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T; Minami Y; Maekawa Y; Oi Y
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synergistic action of streptomycin, PAS, viomycin, and neomycin on Mycobacterium tuberculosis in vitro in 11 various types of association].
    COLETSOS
    Rev Tuberc; 1951; 15(10-11):957-65. PubMed ID: 14912809
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study of the tuberculostatic power of viomycin].
    GERNEZ-RIEUX C; TACQUET A; CHENET C
    Rev Tuberc; 1951; 15(7-8):665-75. PubMed ID: 14883716
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on resistance of tubercle bacilli to reserve drugs. II. Resistance to viomycin and kanamycin in experimenta tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1966 Oct; 34(10):903-6. PubMed ID: 4292274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tuberculostatic action of viomycin in vitro and in vivo].
    GERNEZ-RIEUX C; TACQUET A; CHENET C
    Ann Inst Pasteur (Paris); 1951 Aug; 81(2):158-63. PubMed ID: 14868864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy of tuberculosis; comparative experimental study.
    GOHAR MA; EISSA AA
    J Egypt Med Assoc; 1953; 36(2):107-13. PubMed ID: 13070305
    [No Abstract]   [Full Text] [Related]  

  • 18. The bactericidal activities of combinations of streptomycin, isoniazid, p-aminosalicylic acid (PAS), oxytetracycline (terramycin) and viomycin against Mycobacterium tuberculosis.
    SINGH B; MITCHISON DA
    J Gen Microbiol; 1955 Aug; 13(1):176-84. PubMed ID: 13252227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
    Endo K
    Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.